Category: drugs
-
Better drugs through AI? Insitro CEO on what machine learning can teach Big Pharma
•
Breadcrumb links PMN BMN Business Article writer: Associated Press Matthew Perrone Published on December 02, 2024 • 3 minutes read You can save this article by registering for free here. Or log in if you have an account. (AP illustration/Jenny Soon) Photography by Ap Illustration/Jenny Soon /Associated Press Article content…
-
Gilead Sciences stock upgraded by Raymond James on strong growth outlook for new drugs By Investing.com
•
On Monday, Raymond James changed its stance on Gilead Sciences Inc. (NASDAQ:GIL) stock, upgrading it from “market perform” to “outperform.” The firm also set a $93.00 price target for the biopharmaceutical company. This update is bolstered by promising data from the PURPOSE-1 study of lenacapavir, a long-acting HIV pre-exposure prophylaxis…
-
Appeals court does not block US mandate to cover cancer screenings, HIV drugs By Reuters
•
Written by Brendan Pearson (Reuters) – A U.S. appeals court on Friday declined to block a federal order requiring health insurers to cover preventive care services such as cancer screenings and HIV prevention drugs at no additional cost to patients, but ruled against the government in a major legal case…
-
The exec who decides which drugs Novartis will develop
•
At the beginning of 2023, Dr. Roni (Aharon) Gal, one of the best-known and longest-serving analysts in biopharmaceuticals, surprised the market when he announced his career change. Gall, who was working as a senior analyst at investment bank Sanford Bernstein, crossed the lines and joined pharmaceutical company Novartis as chief…